Conmed Corp
XBER:EC8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Conmed Corp
XBER:EC8
|
US |
|
Cenovus Energy Inc
TSX:CVE
|
CA |
|
Old Mutual Ltd
F:2KS
|
ZA |
|
A
|
Avi Ltd
JSE:AVI
|
ZA |
|
E
|
Elisa Oyj
DUS:EIA
|
FI |
|
C
|
Costco Wholesale Corp
F:CTO
|
US |
|
ArcelorMittal SA
AEX:MT
|
LU |
|
Eastwood Bio-Medical Canada Inc
XTSX:EBM
|
CA |
|
K
|
Kemper Corp
F:UI2
|
US |
|
S
|
SoftBank Group Corp
DUS:SFT
|
JP |
|
S
|
Sarepta Therapeutics Inc
F:AB3A
|
US |
Wall St Price Targets
EC8 Price Targets Summary
Conmed Corp
According to Wall Street analysts, the average 1-year price target for
EC8 is 43.28 EUR with a low forecast of 42.32 EUR and a high forecast of 45.12 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EC8's stock price target?
Price Target
43.28
EUR
According to Wall Street analysts, the average 1-year price target for
EC8 is 43.28 EUR with a low forecast of 42.32 EUR and a high forecast of 45.12 EUR.
What is the Revenue forecast for Conmed Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Conmed Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Conmed Corp?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 31%.
What is the Pre-Tax Income forecast for Conmed Corp?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 44%.
What is the Net Income forecast for Conmed Corp?
Projected CAGR
51%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 51%.